Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy
- 11 January 2018
- journal article
- review article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 29 (3) , 624-634
Abstract
Cell membrane engineering, including live cell membrane bioconjugation and cell membrane-derived nanomaterials is a highly promising strategy to modulate immune responses for treating diseases. Many cell membrane engineering methods have potential for translation for human clinical use in the near future. In this Topical Review, we summarize the cell membrane conjugation strategies that have been investigated for cancer immunotherapy, the prevention of immune rejection to donor cells and tissues, and the induction of antigen-specific tolerance in autoimmune diseases. Additionally, cell membrane-derived or membrane-coated nanomaterials are an emerging class of nanomaterials that is attracting significant attention in the field of nanomedicine. Some of these nanomaterials have been employed to elicit immune responses against cancer, toxins, and bacteria, although their application in establishing immune tolerance has not been explored. In addition to discussing potential problems, we provide our perspectives for promising future directions.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R21AI133372)
This publication has 96 references indexed in Scilit:
- Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticlesBiomaterials, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized ImmunotherapyAngewandte Chemie International Edition, 2011
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticlesNature Medicine, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic DeliveryACS Nano, 2010
- Biological performance of mussel-inspired adhesive in extrahepatic islet transplantationBiomaterials, 2010
- Immunotherapy of autoimmunity and cancer: the penalty for successNature Reviews Immunology, 2008
- ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanismsProceedings of the National Academy of Sciences, 2008